Emily C McGowan, MD, PhD Disclosures: Membership on Advisory Committees or Review Panels, Board Membership, etc.-Takeda Pharmaceuticals (Any division) (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company (Relationship has ended)|Consulting Fee-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-AstraZeneca (Any division) (Relationship has ended) - 11/25/2024 No Bio Available.